It is possible new templates exist for this target since these models were created.
Available Structures
36 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| wildtype ligand binding domain of the glucocorticoid receptor complexed with velsecorat and a PGC1a… |
Heteromer P04150; | 1×82H; | ||||
| Assess | ||||||
| Crystal structure of ligand-binding domain of estrogen-related receptor alpha (ERRalpha) in complex… |
Heteromer P11474; | |||||
| Assess | ||||||
| PPAR mutant complex |
Heteromer P37231; | 1×EDK; | ||||
| Assess | ||||||
| Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with deacetyl… |
Heteromer A0A1X8XLE9; | 1×TUS; 1×GOL; | ||||
| Assess | ||||||
| Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with hydrocor… |
Heteromer | 1×HCY; 3×GOL; 1×TLA; 1×EPE; 2×SCN; | ||||
| Assess | ||||||
| Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with dexameth… |
Heteromer | 1×DEX; 1×FMT; 1×ACE; 2×DMS; 1×GOL; | ||||
| Assess | ||||||
| Ligand binding to FARNESOID-X-RECEPTOR |
Heteromer Q96RI1; | 1×0X0; | ||||
| Assess | ||||||
| Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a |
Heteromer P37231; | 4×SO4; 1×BRL; | ||||
| Assess | ||||||
| Crystal structure of human nuclear receptor sf-1 (nr5a1) bound to its hormone pip3 at 2.4 a resolut… |
Heteromer Q13285; | 1×PIZ; 2×ACT; | ||||
| Assess | ||||||
| The acyl chains of phosphoinositide PIP3 alter the structure and function of nuclear receptor Stero… |
Heteromer Q13285; | 1×WES; | ||||
| Assess | ||||||
| The glucocorticoid receptor in complex with fluticasone furoate, a PGC1a coactivator fragment and s… |
Heteromer P04150; | 4×ZN; 3×EDO; 2×GW6; | ||||
| Assess | ||||||
| Crystal structure of the Estrogen-Related Receptor alpha (ERRalpha) ligand-binding domain (LBD) in … |
Heteromer P11474; | 2×HVO; 1×IOD; | ||||
| Assess | ||||||
| Crystal structure of human nuclear receptor sf-1 (nr5a1) bound to pip2 at 2.8 a resolution |
Heteromer Q13285; | 1×PIK; 5×EDO; | ||||
| Assess | ||||||
| High-resolution structure of unliganded PPAR gamma in complex with the peptide PGC-1 alpha |
Heteromer P37231; | |||||
| Assess | ||||||
| Peroxisome proliferator-activated receptor gamma ligand binding domain in complex with a novel sele… |
Heteromer P37231; | 2×V77; | ||||
| Assess | ||||||
| Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator Cerco-A |
Heteromer P37231; | 1×KRC; | ||||
| Assess | ||||||
| Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator |
Heteromer P37231; | 1×21L; | ||||
| Assess | ||||||
| Peroxisome proliferator-activated receptor gamma ligand binding domain in complex with a novel sele… |
Heteromer P37231; | 1×7MV; | ||||
| Assess | ||||||
| Human PPAR alpha ligand binding domain in complex with a synthetic agonist (compound A) |
Heteromer Q07869; | 1×T02; | ||||
| Assess | ||||||
| Human PPAR alpha ligand binding domain in complex with a synthetic agonist (compound B) |
Heteromer Q07869; | 1×T06; | ||||
| Assess | ||||||
| Peroxisome proliferator-activated receptor gamma in complex with VSP-51-2 |
Heteromer P37231; | 1×SJ9; | ||||
| Assess | ||||||
| Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with Predniso… |
Heteromer A0A1X8XLE9; | 1×TUA; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator |
Heteromer P37231; | 1×17L; | ||||
| Assess | ||||||
| Crystal structure of the PPARgamma-LBD complexed with compound 3g |
Heteromer P37231; | 1×B1O; | ||||
| Assess | ||||||
| Crystal structure of the PPARgamma-LBD complexed with compound 13ab |
Heteromer P37231; | 1×RTE; 2×CL; | ||||
| Assess | ||||||
| Crystal structure of the PPARgamma-LBD complexed with compound DS-6930 |
Heteromer P37231; | 1×RTF; 2×CL; | ||||
| Assess | ||||||
| Crystal structure of the PPARgamma-LBD complexed with compound 1l |
Heteromer P37231; | 1×B0X; | ||||
| Assess | ||||||
| Crystal Structure of PPARgamma Ligand Binding Domain in complex with dibenzooxepine derivative comp… |
Heteromer P37231; | 1×CTU; | ||||
| Assess | ||||||
| Crystal Structure of PPARgamma Ligand Binding Domain in complex with dibenzooxepine derivative comp… |
Heteromer P37231; | 1×KK4; | ||||
| Assess | ||||||
| Structure of PPARg H494Y mutant in complex with GW1929 |
Heteromer P37231; | 1×EDK; | ||||
| Assess | ||||||
| The glucocorticoid receptor in complex with velsecorat, a PGC1a coactivator fragment and sgk 23bp |
Heteromer P04150; | 4×ZN; 6×EDO; 2×82H; | ||||
| Assess | ||||||
| Estrogen-related receptor beta(ERR2) in complex with PGC1a-2a |
Heteromer O95718; | |||||
| Assess | ||||||
| Ligand binding domain of PPARgamma complexed with Decanoic Acid and PGC-1a peptide |
Heteromer P37231; | 1×DKA; | ||||
| Assess | ||||||
| Structure of Human Liver Receptor Homolog 1 in complex with PGC1a and RJW100 |
Heteromer O00482; | 1×RJW; | ||||
| Assess | ||||||
| PPAR gamma complex. |
Heteromer P37231; | 1×EDK; | ||||
| Assess | ||||||
| X-ray structure of ERRalpha LBD in complex with a PGC-1alpha peptide at 2.5A resolution |
Heteromer P11474; | 2×IOD; | ||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5o20.1.A | monomer | 0.56 | 17.33 | |||
| Assess | ||||||
| 5wpa.1.A | monomer | 0.55 | 23.75 | |||
| Assess | ||||||
7 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 5ffx.1.B | monomer | 0.53 | 30.77 | ||
| Assess | ||||||
| Isoform 3 | 5o20.1.A | monomer | 0.55 | 17.33 | ||
| Assess | ||||||
| Isoform 3 | 5wpa.1.A | monomer | 0.54 | 23.75 | ||
| Assess | ||||||
| Isoform 4 | 5o20.1.A | monomer | 0.56 | 17.33 | ||
| Assess | ||||||
| Isoform 4 | 5wpa.1.A | monomer | 0.55 | 23.75 | ||
| Assess | ||||||
| Isoform 9 | 5o20.1.A | monomer | 0.55 | 17.33 | ||
| Assess | ||||||
| Isoform 9 | 5wpa.1.A | monomer | 0.54 | 23.75 | ||
| Assess | ||||||